{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:33:22Z","timestamp":1776087202008,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreastatin (PST) is an endogenous peptide which regulates glucose and lipid metabolism in liver and adipose tissues. In type 2 diabetic patients, PST level is high and plays a crucial role in the negative regulation of insulin sensitivity. Novel therapeutic agents are needed to treat the diabetes and insulin resistance (IR) against the PST action. In this regard, we have investigated the PST inhibitor peptide-8 (PSTi8) action against diabetogenic PST. PSTi8 rescued PST-induced IR in HepG2 and 3T3L1 cells. PSTi8 increases the GLUT4 translocation to cell surface to promote glucose uptake in L6-GLUT4<jats:italic>myc<\/jats:italic> cells. PSTi8 treatment showed an increase in insulin sensitivity in db\/db, high fat and fructose fed streptozotocin (STZ) induced IR mice. PSTi8 improved the glucose homeostasis which is comparable to metformin in diabetic mice, characterized by elevated glucose clearance, enhanced glycogenesis, enhanced glycolysis and reduced gluconeogenesis. PST and PSTi8 both were docked to the GRP78 inhibitor binding site in protein-protein docking, GRP78 expression and its ATPase activity studies. The mechanism of action of PSTi8 may be mediated by activating IRS1\/2-phosphatidylinositol-3-kinase-AKT (FoxO1, Srebp-1c) signaling pathway. The discovery of PSTi8 provides a promising therapeutic agent for the treatment of metabolic diseases mainly diabetes.<\/jats:p>","DOI":"10.1038\/s41598-018-27018-8","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T10:21:54Z","timestamp":1527848514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus"],"prefix":"10.1038","volume":"8","author":[{"given":"Zakir","family":"Hossain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1180-2530","authenticated-orcid":false,"given":"Guru R.","family":"Valicherla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-2222","authenticated-orcid":false,"given":"Mohammed","family":"Riyazuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharat","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad I.","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7703-9307","authenticated-orcid":false,"given":"Jiaur R.","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"27018_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.regpep.2010.10.004","volume":"165","author":"V S\u00e1nchez-Margalet","year":"2010","unstructured":"S\u00e1nchez-Margalet, V., Gonz\u00e1lez-Yanes, C., Najib, S. & Santos-\u00c1lvarez, J. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Regulatory peptides 165, 71\u201377 (2010).","journal-title":"Regulatory peptides"},{"key":"27018_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/324476a0","volume":"324","author":"K Tatemoto","year":"1986","unstructured":"Tatemoto, K. et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324, 476 (1986).","journal-title":"Nature"},{"key":"27018_CR3","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1210\/jc.2005-0408","volume":"90","author":"DT O\u2019connor","year":"2005","unstructured":"O\u2019connor, D. T. et al. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. The Journal of Clinical Endocrinology & Metabolism 90, 5414\u20135425 (2005).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"27018_CR4","doi-asserted-by":"publisher","first-page":"28498","DOI":"10.1074\/jbc.M109.020636","volume":"284","author":"JR Gayen","year":"2009","unstructured":"Gayen, J. R. et al. A Novel Pathway of Insulin Sensitivity in Chromogranin a Null Mice a Crucial Role for Pancreastatin in Glucose Homeostasis. Journal of Biological Chemistry 284, 28498\u201328509 (2009).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1749-6632.2002.tb04518.x","volume":"971","author":"PE Cadman","year":"2002","unstructured":"Cadman, P. E., Rao, F., Mahata, S. K. & O\u2019connor, D. T. Studies of the dysglycemic peptide, pancreastatin, using a human forearm model. Annals of the New York Academy of Sciences 971, 528\u2013529 (2002).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"27018_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1152\/physiolgenomics.00131.2013","volume":"45","author":"GR Valicherla","year":"2013","unstructured":"Valicherla, G. R., Hossain, Z., Mahata, S. K. & Gayen, J. R. Pancreastatin is an endogenous peptide that regulates glucose homeostasis. Physiological genomics 45, 1060\u20131071 (2013).","journal-title":"Physiological genomics"},{"key":"27018_CR7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2337\/diacare.21.11.1951","volume":"21","author":"V Sanchez-Margalet","year":"1998","unstructured":"Sanchez-Margalet, V. et al. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels. Diabetes care 21, 1951\u20131954 (1998).","journal-title":"Diabetes care"},{"key":"27018_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0167-0115(90)90056-3","volume":"30","author":"A Funakoshi","year":"1990","unstructured":"Funakoshi, A., Tateishi, K., Shinozaki, H., Matsumoto, M. & Wakasugi, H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regulatory peptides 30, 159\u2013164 (1990).","journal-title":"Regulatory peptides"},{"key":"27018_CR9","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1074\/jbc.M113.520916","volume":"289","author":"PK Allu","year":"2014","unstructured":"Allu, P. K. et al. Naturally Occurring Variants of the Dysglycemic Peptide Pancreastatin Differential Potencies for Multiple Cellular Functions and Structure-Function Correlation. Journal of Biological Chemistry 289, 4455\u20134469 (2014).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cellsig.2005.08.009","volume":"18","author":"G-Y Carmen","year":"2006","unstructured":"Carmen, G.-Y. & V\u00edctor, S.-M. Signalling mechanisms regulating lipolysis. Cellular signalling 18, 401\u2013408 (2006).","journal-title":"Cellular signalling"},{"key":"27018_CR11","doi-asserted-by":"publisher","first-page":"e84132","DOI":"10.1371\/journal.pone.0084132","volume":"9","author":"N Biswas","year":"2014","unstructured":"Biswas, N. et al. Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism. PloS one 9, e84132 (2014).","journal-title":"PloS one"},{"key":"27018_CR12","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1074\/jbc.M411871200","volume":"280","author":"T Yasukawa","year":"2005","unstructured":"Yasukawa, T. et al. S-nitrosylation-dependent inactivation of Akt\/protein kinase B in insulin resistance. Journal of Biological Chemistry 280, 7511\u20137518 (2005).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2337\/db13-1747","volume":"64","author":"GK Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay, G. K. et al. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance. Diabetes 64, 104\u2013116 (2015).","journal-title":"Diabetes"},{"key":"27018_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/bbrc.2001.5967","volume":"289","author":"C Gonz\u00e1lez-Yanes","year":"2001","unstructured":"Gonz\u00e1lez-Yanes, C. & S\u00e1nchez-Margalet, V. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. Biochemical and biophysical research communications 289, 282\u2013287 (2001).","journal-title":"Biochemical and biophysical research communications"},{"key":"27018_CR15","doi-asserted-by":"publisher","first-page":"47898","DOI":"10.1074\/jbc.M408149200","volume":"279","author":"M Zang","year":"2004","unstructured":"Zang, M. et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. Journal of Biological Chemistry 279, 47898\u201347905 (2004).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR16","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","volume":"289","author":"J Cao","year":"2014","unstructured":"Cao, J. et al. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). Journal of Biological Chemistry 289, 20435\u201320446 (2014).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR17","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1210\/endo.141.11.7771","volume":"141","author":"RA Memon","year":"2000","unstructured":"Memon, R. A. et al. Up-regulation of peroxisome proliferator-activated receptors (PPAR-\u03b1) and PPAR-\u03b3 messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-\u03b3-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141, 4021\u20134031 (2000).","journal-title":"Endocrinology"},{"key":"27018_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11010-008-9968-1","volume":"323","author":"A Yessoufou","year":"2009","unstructured":"Yessoufou, A. et al. Peroxisome proliferator-activated receptor-\u03b1 modulates insulin gene transcription factors and inflammation in adipose tissues in mice. Molecular and cellular biochemistry 323, 101 (2009).","journal-title":"Molecular and cellular biochemistry"},{"key":"27018_CR19","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1210\/jc.2007-2472","volume":"93","author":"S Fern\u00e1ndez-Veledo","year":"2008","unstructured":"Fern\u00e1ndez-Veledo, S. et al. Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes. The Journal of Clinical Endocrinology & Metabolism 93, 2866\u20132876 (2008).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"27018_CR20","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"Aguirre, V., Uchida, T., Yenush, L., Davis, R. & White, M. F. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. Journal of Biological Chemistry 275, 9047\u20139054 (2000).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/sj.leu.2403653","volume":"19","author":"V Grandage","year":"2005","unstructured":"Grandage, V., Gale, R., Linch, D. & Khwaja, A. PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways. Leukemia 19, 586 (2005).","journal-title":"Leukemia"},{"key":"27018_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell metabolism 13, 376\u2013388 (2011).","journal-title":"Cell metabolism"},{"key":"27018_CR23","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1017\/S000711450000088X","volume":"83","author":"JC Seidell","year":"2000","unstructured":"Seidell, J. C. Obesity, insulin resistance and diabetes\u2014a worldwide epidemic. British Journal of Nutrition 83, S5\u2013S8 (2000).","journal-title":"British Journal of Nutrition"},{"key":"27018_CR24","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin, L. & Magistretti, P. J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proceedings of the National Academy of Sciences 91, 10625\u201310629 (1994).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"27018_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0026-0495(89)90129-7","volume":"38","author":"RA DeFronzo","year":"1989","unstructured":"DeFronzo, R. A., Ferrannini, E. & Simonson, D. C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38, 387\u2013395 (1989).","journal-title":"Metabolism"},{"key":"27018_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0065-2571(66)90016-1","volume":"4","author":"E Struck","year":"1966","unstructured":"Struck, E., Ashmore, J. & Wieland, O. Effects of glucagon and long chain fatty acids on glucose production by isolated perfused rat liver. Advances in enzyme regulation 4, 219\u2013224 (1966).","journal-title":"Advances in enzyme regulation"},{"key":"27018_CR27","doi-asserted-by":"publisher","first-page":"E1055","DOI":"10.1152\/ajpendo.1998.275.6.E1055","volume":"275","author":"V S\u00e1nchez-Margalet","year":"1998","unstructured":"S\u00e1nchez-Margalet, V. & Gonz\u00e1lez-Yanes, C. Pancreastatin inhibits insulin action in rat adipocytes. American Journal of Physiology-Endocrinology and Metabolism 275, E1055\u2013E1060 (1998).","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"27018_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847 (2006).","journal-title":"Nature"},{"key":"27018_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang, H. & Ward, W. F. PGC-1\u03b1: a key regulator of energy metabolism. Advances in physiology education 30, 145\u2013151 (2006).","journal-title":"Advances in physiology education"},{"key":"27018_CR30","doi-asserted-by":"crossref","first-page":"27773","DOI":"10.1016\/S0021-9258(18)47053-6","volume":"269","author":"KM Waters","year":"1994","unstructured":"Waters, K. M. & Ntambi, J. M. Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice. Journal of Biological Chemistry 269, 27773\u201327777 (1994).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1210\/me.2009-0091","volume":"24","author":"JJ Tomlinson","year":"2010","unstructured":"Tomlinson, J. J. et al. Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors. Molecular Endocrinology 24, 104\u2013113 (2010).","journal-title":"Molecular Endocrinology"},{"key":"27018_CR32","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00125-006-0357-6","volume":"49","author":"B Brunmair","year":"2006","unstructured":"Brunmair, B. et al. Activation of PPAR-\u03b4 in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 49, 2713\u20132722 (2006).","journal-title":"Diabetologia"},{"key":"27018_CR33","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1074\/jbc.M008010200","volume":"276","author":"E Chevillotte","year":"2001","unstructured":"Chevillotte, E., Rieusset, J., Roques, M., Desage, M. & Vidal, H. The regulation of uncoupling protein-2 gene expression by \u03c9-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor \u03b2. Journal of Biological Chemistry 276, 10853\u201310860 (2001).","journal-title":"Journal of Biological Chemistry"},{"key":"27018_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0026-0495(98)90027-0","volume":"47","author":"J Luo","year":"1998","unstructured":"Luo, J. et al. Nongenetic mouse models of non\u2014insulin-dependent diabetes mellitus. Metabolism 47, 663\u2013668 (1998).","journal-title":"Metabolism"},{"key":"27018_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/jmf.2009.0110","volume":"13","author":"JG Babish","year":"2010","unstructured":"Babish, J. G. et al. Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db\/db mice. Journal of medicinal food 13, 535\u2013547 (2010).","journal-title":"Journal of medicinal food"},{"key":"27018_CR36","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.lfs.2004.10.051","volume":"76","author":"BKH Tan","year":"2005","unstructured":"Tan, B. K. H., Tan, C. H. & Pushparaj, P. N. Anti\u2013diabetic activity of the semi\u2013purified fractions of Averrhoa bilimbi in high fat diet fed\u2013streptozotocin\u2013induced diabetic rats. Life sciences 76, 2827\u20132839 (2005).","journal-title":"Life sciences"},{"key":"27018_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. & Ramarao, P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological research 52, 313\u2013320 (2005).","journal-title":"Pharmacological research"},{"key":"27018_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/dc11-1107","volume":"35","author":"D Russell-Jones","year":"2012","unstructured":"Russell-Jones, D. et al. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes care 35, 252\u2013258 (2012).","journal-title":"Diabetes care"},{"key":"27018_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.7150\/ijbs.10809","volume":"11","author":"M Li","year":"2015","unstructured":"Li, M. et al. Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice. International journal of biological sciences 11, 472 (2015).","journal-title":"International journal of biological sciences"},{"key":"27018_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbrc.2007.06.044","volume":"360","author":"F Haubner","year":"2007","unstructured":"Haubner, F. et al. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell. Biochemical and biophysical research communications 360, 560\u2013565 (2007).","journal-title":"Biochemical and biophysical research communications"},{"key":"27018_CR41","unstructured":"Mahata, S. K., Bandyopadhyay, G. K. & Senapati, S. (Google Patents, 2017)."},{"key":"27018_CR42","doi-asserted-by":"crossref","unstructured":"Wang, C.-Y. & Liao, J. K. In mTOR 421\u2013433 (Springer, 2012).","DOI":"10.1007\/978-1-61779-430-8_27"},{"key":"27018_CR43","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/sj.bjp.0703829","volume":"132","author":"K Arakawa","year":"2001","unstructured":"Arakawa, K. et al. Improved diabetic syndrome in C57BL\/KsJ\u2010db\/db mice by oral administration of the Na+\u2010glucose cotransporter inhibitor T\u20101095. British journal of pharmacology 132, 578\u2013586 (2001).","journal-title":"British journal of pharmacology"},{"key":"27018_CR44","doi-asserted-by":"crossref","unstructured":"Tsiotra, P. C., Boutati, E., Dimitriadis, G. & Raptis, S. A. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. BioMed research international 2013 (2012).","DOI":"10.1155\/2013\/487081"},{"key":"27018_CR45","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2015.09.013","volume":"22","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y. et al. Leptin deficiency shifts mast cells toward anti-inflammatory actions and protects mice from obesity and diabetes by polarizing M2 macrophages. Cell metabolism 22, 1045\u20131058 (2015).","journal-title":"Cell metabolism"},{"key":"27018_CR46","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. The Journal of clinical investigation 115, 1343\u20131351 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"27018_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bbrc.2007.05.171","volume":"360","author":"H-i Kim","year":"2007","unstructured":"Kim, H.-i et al. Transcriptional activation of SHP by PPAR-\u03b3 in liver. Biochemical and biophysical research communications 360, 301\u2013306 (2007).","journal-title":"Biochemical and biophysical research communications"},{"key":"27018_CR48","doi-asserted-by":"crossref","unstructured":"Saad, M. I., Kamel, M. A. & Hanafi, M. Y. Modulation of adipocytokines production and serum NEFA level by metformin, glimepiride, and sitagliptin in HFD\/STZ diabetic rats. Biochemistry research international 2015 (2015).","DOI":"10.1155\/2015\/138134"},{"key":"27018_CR49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2011.11.118","volume":"417","author":"N Yamagishi","year":"2012","unstructured":"Yamagishi, N., Ueda, T., Mori, A., Saito, Y. & Hatayama, T. Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice. Biochemical and biophysical research communications 417, 364\u2013370 (2012).","journal-title":"Biochemical and biophysical research communications"},{"key":"27018_CR50","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0327","volume":"220","author":"S Guo","year":"2014","unstructured":"Guo, S. Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms. Journal of Endocrinology 220, T1\u2013T23 (2014).","journal-title":"Journal of Endocrinology"},{"key":"27018_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5483\/BMBRep.2013.46.12.248","volume":"46","author":"K-J Oh","year":"2013","unstructured":"Oh, K.-J., Han, H.-S., Kim, M.-J. & Koo, S.-H. CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB reports 46, 567 (2013).","journal-title":"BMB reports"},{"key":"27018_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies, J. L. et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell metabolism 14, 21\u201332 (2011).","journal-title":"Cell metabolism"},{"key":"27018_CR53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1373\/clinchem.2008.115352","volume":"55","author":"JA Menendez","year":"2009","unstructured":"Menendez, J. A., Vazquez-Martin, A., Ortega, F. J. & Fernandez-Real, J. M. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clinical chemistry 55, 425\u2013438 (2009).","journal-title":"Clinical chemistry"},{"key":"27018_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0014-5793(98)00423-2","volume":"427","author":"Q Wang","year":"1998","unstructured":"Wang, Q., Khayat, Z., Kishi, K., Ebina, Y. & Klip, A. GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS letters 427, 193\u2013197 (1998).","journal-title":"FEBS letters"},{"key":"27018_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mce.2013.02.013","volume":"370","author":"J Prasad","year":"2013","unstructured":"Prasad, J. et al. Diastereomeric mixture of calophyllic acid and isocalophyllic acid stimulates glucose uptake in skeletal muscle cells: Involvement of PI-3-Kinase-and ERK1\/2-dependent pathways. Molecular and cellular endocrinology 370, 11\u201319 (2013).","journal-title":"Molecular and cellular endocrinology"},{"key":"27018_CR56","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1016\/S0264-410X(01)00203-1","volume":"19","author":"JE Suarez","year":"2001","unstructured":"Suarez, J. E. et al. Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells. Vaccine 19, 4487\u20134495 (2001).","journal-title":"Vaccine"},{"key":"27018_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC bioinformatics 9, 40 (2008).","journal-title":"BMC bioinformatics"},{"key":"27018_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biomaterials.2015.03.046","volume":"56","author":"JK Tripathi","year":"2015","unstructured":"Tripathi, J. K. et al. Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties. Biomaterials 56, 92\u2013103 (2015).","journal-title":"Biomaterials"},{"key":"27018_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep41009","volume":"7","author":"BN Kanuri","year":"2017","unstructured":"Kanuri, B. N. et al. Altered glucose and lipid homeostasis in liver and adipose tissue pre-dispose inducible NOS knockout mice to insulin resistance. Scientific reports 7, 41009 (2017).","journal-title":"Scientific reports"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27018-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27018-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:12:01Z","timestamp":1671603121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27018-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27018"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27018-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8715"}}